Baidu
map

中国呼吸危重症患者营养支持治疗专家共识

2020-03-03 中国医师协会呼吸医师分会 中华医学杂志.2020,100(8):573-585.

近年来,针对危重症患者营养支持治疗的临床实施,美国危重症协会(SCCM)与美国肠外肠内营养协会(ASPEN,2016),欧洲肠外肠内营养协会(ESPEN,2018)等制定的国际指南已发布了明确的推荐意

中文标题:

中国呼吸危重症患者营养支持治疗专家共识

发布日期:

2020-03-03

简要介绍:

近年来,针对危重症患者营养支持治疗的临床实施,美国危重症协会(SCCM)与美国肠外肠内营养协会(ASPEN,2016),欧洲肠外肠内营养协会(ESPEN,2018)等制定的国际指南已发布了明确的推荐意见。而呼吸危重症患者有其疾病代谢和治疗方式的特殊性,有关呼吸危重症的营养支持治疗策略尚无统一的共识和指南推荐。随着临床营养学的快速发展,关于呼吸危重症患者是否可以通过营养支持治疗提高生存率、缩短ICU住院时间、改善患者生活质量等方面的国内外研究日益增多。为求规范呼吸危重症患者的营养支持治疗,国内呼吸危重症和营养学的专家们对相关的循证医学证据进行了系统地检索、筛选、评价,包括高质量的系统回顾、荟萃分析和相关的RCT研究。对呼吸危重症患者营养支持治疗实施过程中医务人员最为关注的22个问题进行了多轮讨论,经过专家投票计分最终确定24条推荐意见。

下载附件:

(因为版权问题,不支持下载)

评论区 (35)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1179901, encodeId=e39711e990160, content=非常具体化,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20e2880331, createdName=zhangjie17076349, createdTime=Mon Jan 03 01:07:24 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078228, encodeId=e28410e8228a1, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210809/ad098dd9e1974981975c3e5164b1e05d/8e3bab002ce344ddbcd7632c3d7a3a64.jpg, createdBy=2f582169660, createdName=玉兰儿, createdTime=Wed Dec 08 22:14:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064362, encodeId=58e710643629a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2af15433846, createdName=ms4000002002022924, createdTime=Wed Oct 27 14:02:10 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059285, encodeId=d3b2105928584, content=怎么看全文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f05a5630994, createdName=ms6000002051502090, createdTime=Sun Oct 10 23:16:26 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059353, encodeId=c11810593530d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72e95206888, createdName=文H, createdTime=Mon Oct 11 09:54:04 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2022-01-03 zhangjie17076349

    非常具体化,实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1179901, encodeId=e39711e990160, content=非常具体化,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20e2880331, createdName=zhangjie17076349, createdTime=Mon Jan 03 01:07:24 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078228, encodeId=e28410e8228a1, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210809/ad098dd9e1974981975c3e5164b1e05d/8e3bab002ce344ddbcd7632c3d7a3a64.jpg, createdBy=2f582169660, createdName=玉兰儿, createdTime=Wed Dec 08 22:14:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064362, encodeId=58e710643629a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2af15433846, createdName=ms4000002002022924, createdTime=Wed Oct 27 14:02:10 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059285, encodeId=d3b2105928584, content=怎么看全文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f05a5630994, createdName=ms6000002051502090, createdTime=Sun Oct 10 23:16:26 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059353, encodeId=c11810593530d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72e95206888, createdName=文H, createdTime=Mon Oct 11 09:54:04 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-12-08 玉兰儿

    学习啦

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1179901, encodeId=e39711e990160, content=非常具体化,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20e2880331, createdName=zhangjie17076349, createdTime=Mon Jan 03 01:07:24 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078228, encodeId=e28410e8228a1, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210809/ad098dd9e1974981975c3e5164b1e05d/8e3bab002ce344ddbcd7632c3d7a3a64.jpg, createdBy=2f582169660, createdName=玉兰儿, createdTime=Wed Dec 08 22:14:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064362, encodeId=58e710643629a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2af15433846, createdName=ms4000002002022924, createdTime=Wed Oct 27 14:02:10 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059285, encodeId=d3b2105928584, content=怎么看全文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f05a5630994, createdName=ms6000002051502090, createdTime=Sun Oct 10 23:16:26 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059353, encodeId=c11810593530d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72e95206888, createdName=文H, createdTime=Mon Oct 11 09:54:04 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-27 ms4000002002022924

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1179901, encodeId=e39711e990160, content=非常具体化,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20e2880331, createdName=zhangjie17076349, createdTime=Mon Jan 03 01:07:24 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078228, encodeId=e28410e8228a1, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210809/ad098dd9e1974981975c3e5164b1e05d/8e3bab002ce344ddbcd7632c3d7a3a64.jpg, createdBy=2f582169660, createdName=玉兰儿, createdTime=Wed Dec 08 22:14:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064362, encodeId=58e710643629a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2af15433846, createdName=ms4000002002022924, createdTime=Wed Oct 27 14:02:10 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059285, encodeId=d3b2105928584, content=怎么看全文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f05a5630994, createdName=ms6000002051502090, createdTime=Sun Oct 10 23:16:26 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059353, encodeId=c11810593530d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72e95206888, createdName=文H, createdTime=Mon Oct 11 09:54:04 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-10 ms6000002051502090

    怎么看全文

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1179901, encodeId=e39711e990160, content=非常具体化,实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a20e2880331, createdName=zhangjie17076349, createdTime=Mon Jan 03 01:07:24 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078228, encodeId=e28410e8228a1, content=学习啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210809/ad098dd9e1974981975c3e5164b1e05d/8e3bab002ce344ddbcd7632c3d7a3a64.jpg, createdBy=2f582169660, createdName=玉兰儿, createdTime=Wed Dec 08 22:14:45 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064362, encodeId=58e710643629a, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2af15433846, createdName=ms4000002002022924, createdTime=Wed Oct 27 14:02:10 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059285, encodeId=d3b2105928584, content=怎么看全文 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f05a5630994, createdName=ms6000002051502090, createdTime=Sun Oct 10 23:16:26 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059353, encodeId=c11810593530d, content=有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72e95206888, createdName=文H, createdTime=Mon Oct 11 09:54:04 CST 2021, time=2021-10-11, status=1, ipAttribution=)]
    2021-10-11 文H

    有用

    0

拓展阅读

2017 SCCM/ASPEN指南:儿科危重患者营养支持治疗的评估和规定

美国重症医学会(SCCM,Society of Critical Care Medicine) · 2017-07-10

中国重症儿童评估和营养支持治疗指南(英文版)

中国儿科相关医学专家组(统称) · 2018-08-28

2021 ASPEN指南:成人危重症患者的营养支持治疗

美国肠外肠内营养学会(ASPEN,American Society for Parenteral and Enteral Nutrition) · 2021-11-16

新型冠状病毒感染患者营养支持治疗专家建议(2023)

北京市临床营养治疗质量控制与改进中心 · 2023-01-31

营养不良肿瘤患者营养支持治疗临床建议路径

中国科技大学附属第一医院西区(安徽省肿瘤医院) · 2023-01-13

法国专家共识:胰腺癌的营养支持

法国专家小组(统称) · 2023-06-24

Baidu
map
Baidu
map
Baidu
map